RxDoctor Payments Data

Shonna Johnson, MD

Family Medicine · Hampton, VANPI 1679776728

Payments from drug & device makers

$474in general payments, 2019–2025

Across 25 payments — averaging $18.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$172
  • Novo Nordisk$141
  • GSK$55
  • Amgen$36
  • Kowa Pharmaceuticals America, Inc.$33
  • Abbott$24
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$44193%
  • Education$327%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$474 in reported general payments places this provider in the 55th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$198,042
Medicare patients
280
Services billed
5,432

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide183$222,870
MounjaroTirzepatide57$79,842
JardianceEmpagliflozin64$68,773
JanuviaSitagliptin Phosphate49$58,684
TrulicityDulaglutide41$53,919
EliquisApixaban42$30,643
LinzessLinaclotide22$29,921
XareltoRivaroxaban20$28,355
MyrbetriqMirabegron15$14,485
Lantus SolostarInsulin Glargine,hum.Rec.Anlog88$12,356
FarxigaDapagliflozin Propanediol11$8,931
Rosuvastatin Calcium432$4,471
Albuterol Sulfate HfaAlbuterol Sulfate188$4,161
Varenicline Tartrate26$4,083
Metoprolol Succinate303$3,397

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$141$222,870183 claims
Lilly USA, LLCMounjaro, Trulicity$172$133,76198 claims
AstraZenecaFarxiga$13$8,93111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Hampton

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →